These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3063228)

  • 1. [Pathogeny of the hemolytic and uremic syndrome. Recent concepts].
    Loirat C; Schlegel N
    Arch Fr Pediatr; 1988 Oct; 45(8):523-6. PubMed ID: 3063228
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolytic-uremic syndrome: absence of circulating endotoxin.
    van Wieringen PM; Monnens LA; Bakkeren JA
    Pediatrics; 1976 Oct; 58(4):561-3. PubMed ID: 972798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemolytic-uremic syndromes (microangiopathic hemolytic anemias)].
    Judkiewicz L
    Pol Tyg Lek; 1975 Sep; 30(39):1629-31. PubMed ID: 1103099
    [No Abstract]   [Full Text] [Related]  

  • 4. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
    Furlan M
    Adv Nephrol Necker Hosp; 2000; 30():71-81. PubMed ID: 11068635
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemolytic uremic syndrome: abnormalities of prostacyclin in the recurrent form].
    Yoshioka K; Ohno H; Okada M; Maki S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):461-7. PubMed ID: 3528598
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood.
    Monnens L; van de Meer W; Langenhuysen C; van Munster P; van Oostrom C
    Clin Nephrol; 1985 Sep; 24(3):135-7. PubMed ID: 4042442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemolytic-uremic syndrome is a syndrome.
    Kaplan BS; Drummond KN
    N Engl J Med; 1978 Apr; 298(17):964-6. PubMed ID: 642978
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions.
    Defreyn G; Proesmans W; Machin SJ; Lemmens F; Vermylen J
    Clin Nephrol; 1982 Jul; 18(1):43-9. PubMed ID: 6749362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives.
    Túri S; Beattie TJ; Belch JJ; Murphy AV
    Clin Nephrol; 1986 Apr; 25(4):193-8. PubMed ID: 3516482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome.
    Stuart MJ; Spitzer RE; Coppe D
    Pediatrics; 1983 Jan; 71(1):120-4. PubMed ID: 6336835
    [No Abstract]   [Full Text] [Related]  

  • 11. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest.
    Neill MA; Tarr PI; Clausen CR; Christie DL; Hickman RO
    Pediatrics; 1987 Jul; 80(1):37-40. PubMed ID: 3299236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic-uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2.
    Bloom A; Hannaford PA; Greaves M; Preston FE; Brown CB
    Clin Nephrol; 1985 Feb; 23(2):85-8. PubMed ID: 3886228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular platelet activation in the hemolytic uremic syndrome.
    Walters MD; Levin M; Smith C; Nokes TJ; Hardisty RM; Dillon MJ; Barratt TM
    Kidney Int; 1988 Jan; 33(1):107-15. PubMed ID: 3280851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced platelet aggregation in hemolytic-uremic syndrome.
    Kaplan BS; Fong JS
    Thromb Haemost; 1980 Jun; 43(2):154-7. PubMed ID: 7455975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro prostacyclin production in the hemolytic-uremic syndrome.
    Siegler RL; Smith JB; Lynch MB; Mohammad SF
    West J Med; 1986 Feb; 144(2):165-8. PubMed ID: 3754077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How is hemolytic-uremic syndrome in childhood acquired in Switzerland?].
    Kernland KH; Laux-End R; Truttmann AC; Reymond D; Bianchetti MG
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1229-33. PubMed ID: 9333932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome.
    Pysher TJ; Siegler RL; Tesh VL; Taylor FB
    Pediatr Dev Pathol; 2002; 5(5):472-9. PubMed ID: 12196894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemolytic uremic syndrome. Treatment by plasma exchange].
    Pedersen RS; Jørgensen KA
    Ugeskr Laeger; 1981 Oct; 143(43):2800-2. PubMed ID: 7034335
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera.
    Watarai S; Yokota K; Tana ; Kishimoto T; Kanadani T; Taketa K; Oguma K
    J Clin Microbiol; 2001 Feb; 39(2):798-800. PubMed ID: 11158156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic-uremic syndrome (author's transl)].
    Nomura T
    Nihon Rinsho; 1981; 39(12):3666-73. PubMed ID: 7040728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.